Andrea Frilling

Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial

Gunnar Folprecht, Thomas Gruenberger, Wolf O. Bechstein et al. · The Lancet Oncology · 2009 · 953 citations

Hepatology, Gastrointestinal Oncology, Medicine +8

Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC

Lois M. Mulligan, Charis Eng, Catherine S. Healey et al. · Nature Genetics · 1994 · 651 citations

Genetic Disorder, Medicine, Genetics +8

Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study)

Riccardo Lencioni, Laura Crocetti, Roberto Cioni et al. · The Lancet Oncology · 2008 · 521 citations

Radiation Therapy, Medicine, Multicentre Clinical Trial +9

A Limited Set of Human MicroRNA Is Deregulated in Follicular Thyroid Carcinoma

Frank Weber, Rosemary E. Teresi, Christoph E. Broelsch et al. · The Journal of Clinical Endocrinology & Metabolism · 2006 · 296 citations · Full text

Incidence of Finding Residual Disease for Incidental Gallbladder Carcinoma: Implications for Re-resection

Timothy M. Pawlik, Ana Gleisner, Luca Viganò et al. · Journal of Gastrointestinal Surgery · 2007 · 279 citations

Surgical Oncology, Eus-guided Gallbladder Drainage, Biliary Tract +8